Acorda Therapeutics Inc
Drug Manufacturers-Specialty & Generic
Healthcare
ACOR
1.24 M shares
NASDAQ US
traded
02 Jan 2024
listed
no
open
14.86
52 week high
17.60
high
15.26
52 week low
1.33
low
14.51
growth
49.05 %
previous Close
15.09
P/E ratio
-2
market cap
20.64 M
div yield
0
usd
Jun 2023
qoq
revenue
29.68 M
0.00 %
net incoming
-9.38 M
0.00 %
eps
-7.55 %
-428.19 %
eps surprise
0.00 %
net profit margin
-31.61 %
-31.00 %
operating incoming
-3.63 M
0.00 %
net change in cash
332 K
0.00 %
cash on hand
25.27 M
0.00 %
cost of revenue
3.07 M
0.00 %
top top